TC BioPharm Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TC BioPharm Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10954
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TC BioPharm Ltd (TC BioPharm) is an immunotherapy company that develops cell based products for treatment of cancer and viral infection. The company pipeline products are intended for the treatment of ovarian cancer, breast cancer and epidermolysisbullosa related disease, among others. It works in collaboration with various cancer centers in Glasgow, Edinburgh and Southampton; in the UK to develop ImmuniCell, among others. TC BioPharm provides clinical manufacturing facility which is located in Holytown, Scotland, the UK. The company operates in the UK. TC BioPharm is headquartered in Edinburgh, the UK.

TC BioPharm Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TC BioPharm Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TC BioPharm Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
TC BioPharm Raises More Than USD7.8 Million in Series A Financing Round 11
TC BioPharm Raises USD1.1 million in Venture Financing 12
TC BioPharm Raises USD0.4 Million Through Seed Funding 13
TC BioPharm Raises USD2 Million in Venture Financing 14
Partnerships 15
TC BioPharm and Scotia Biologics Enter into Agreement 15
TC Biopharm and Nipro Enter into Co-Development Partnership 16
TC BioPharm Enters into Co-Development Agreement with Sistemic 17
Licensing Agreements 18
bluebird bio Enters into Licensing Agreement with TC BioPharm 18
TC BioPharm Enters into Licensing Agreement with University College London 19
TC BioPharm Enters into Licensing Agreement with Medinet 20
TC BioPharm Ltd – Key Competitors 21
TC BioPharm Ltd – Key Employees 22
TC BioPharm Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Strategy And Business Planning 24
Feb 14, 2018: Scottish Immunotherapy Company TC Biopharm Opens First Overseas Office in Japan 24
Product News 25
08/02/2017: TCB Selected For EU Horizon 2020 Funding to Progress Novel, Mass-Market Cell Therapies to Clinical Trial 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Key Facts 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TC BioPharm Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TC BioPharm Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
TC BioPharm Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TC BioPharm Raises More Than USD7.8 Million in Series A Financing Round 11
TC BioPharm Raises USD1.1 million in Venture Financing 12
TC BioPharm Raises USD0.4 Million Through Seed Funding 13
TC BioPharm Raises USD2 Million in Venture Financing 14
TC BioPharm and Scotia Biologics Enter into Agreement 15
TC Biopharm and Nipro Enter into Co-Development Partnership 16
TC BioPharm Enters into Co-Development Agreement with Sistemic 17
bluebird bio Enters into Licensing Agreement with TC BioPharm 18
TC BioPharm Enters into Licensing Agreement with University College London 19
TC BioPharm Enters into Licensing Agreement with Medinet 20
TC BioPharm Ltd, Key Competitors 21
TC BioPharm Ltd, Key Employees 22
TC BioPharm Ltd, Other Locations 23

List of Figures
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TC BioPharm Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[TC BioPharm Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • F&C Investment Trust PLC:企業の戦略・SWOT・財務分析
    F&C Investment Trust PLC - Strategy, SWOT and Corporate Finance Report Summary F&C Investment Trust PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Aixtron SE (AIXA):企業の財務・戦略的SWOT分析
    Aixtron SE (AIXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Einstein Noah Restaurant Group, Inc. (Foodservice):企業の戦略・SWOT・財務情報
    Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Academic Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Academic Medical Center (AMC), a subsidiary of University of Amsterdam is a medical center that offers research and educational services. The center offers services such as medical research, treatment of patients, and medical education services, among others. It provides its medical treatmen …
  • Ford Motor Company:企業の戦略・SWOT・財務情報
    Ford Motor Company - Strategy, SWOT and Corporate Finance Report Summary Ford Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nine Entertainment Co. Holdings Ltd:企業の戦略・SWOT・財務情報
    Nine Entertainment Co. Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Nine Entertainment Co. Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • AutoCanada Inc.:企業のM&A・事業提携・投資動向
    AutoCanada Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AutoCanada Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Hyundai Engineering & Construction Co Ltd (000720):電力:M&Aディール及び事業提携情報
    Summary Hyundai Engineering & Construction Co Ltd (Hyundai E&C), a subsidiary of Hyundai Motor Co, is an engineering and construction contracting company. It provides civil and construction works for roads, bridges, harbors, highways and railways. It also undertakes property development of residenti …
  • Natera Inc (NTRA):企業の製品パイプライン分析2018
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • Canadian Natural Resources, Ltd.:企業の戦略・SWOT・財務分析
    Canadian Natural Resources, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Canadian Natural Resources, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Grupa Azoty SA (ATT):企業の財務・戦略的SWOT分析
    Grupa Azoty SA (ATT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Agilvax Inc-製薬・医療分野:企業M&A・提携分析
    Summary Agilvax Inc (Agilvax) is a drug company that discovers and develops vaccines against infectious diseases and immunotherapies to treat cancer. The company develops products based on a proprietary virus-like particle platform technology. It develops immunotherapies to treat breast cancer, lung …
  • Infinite Group Inc (IMCI):企業の財務・戦略的SWOT分析
    Summary Infinite Group Inc (IGI) is a technology company that offers IT service and support solutions virtualization and cybersecurity. The company offers Nodeware, an automated network vulnerability management system that assesses vulnerabilities in a computer network using scanning technology. Its …
  • Credicorp Ltd (BAP):企業の財務・戦略的SWOT分析
    Credicorp Ltd (BAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • DONG Energy Salg & Service AS:企業の戦略的SWOT分析
    DONG Energy Salg & Service AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Korea Petrochemical Ind. Co Ltd (006650):企業の財務・戦略的SWOT分析
    Summary Korea Petrochemical Ind. Co Ltd (KPICL) is a chemical company that manufactures and markets petrochemical products. The company provides products such as olefins, aromatics, polypropylene, EO and EG, PP and HDPE. It provides olefins products such as ethylene, propylene, butene, butane, isobu …
  • Ebara Corp (6361):企業の財務・戦略的SWOT分析
    Ebara Corp (6361) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mtr Corporation Ltd
    Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Marubun Corporation:企業の戦略・SWOT・財務分析
    Marubun Corporation - Strategy, SWOT and Corporate Finance Report Summary Marubun Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • QIAGEN N.V.:企業の戦略・SWOT・財務情報
    QIAGEN N.V. - Strategy, SWOT and Corporate Finance Report Summary QIAGEN N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆